Clinical Trials Directory

Trials / Unknown

UnknownNCT05329142

ASSIST: A Surveillance Study of Illicit Substance Toxicity

ASSIST: A Surveillance Study of Illicit Substance Toxicity - Clinical Characterisation and Toxicological Analysis of Emergency Department Presentations in Glasgow

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
NHS Greater Glasgow and Clyde · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

There is a drug-related death crisis in Scotland. This study aims to collaborate with Public Health Scotland in order to assess the feasibility of introducing a surveillance system to the Emergency Department to highlight illicit drug-related attendances. This will utilise both clinical data and toxiclogical analysis of anonymised samples. The data will inform of prevalence, trend data and utcome of ED patients attending with acute illict drug toxicity.

Detailed description

The purpose of this research is to establish the introduction of a robust toxicology surveillance system in the Emergency Department (ED) in order to inform public health interests. The study will explore the feasibility of reporting characteristics and causative agents of patients attending hospital as an emergency due illicit substance use. The term illicit substance used during this study encompasses any substance which is not prescribed to the individual and is a controlled drug as per the Misuse of Drugs act 1971 and Misuse of Drugs Regulations 2001. The study will look at standard care clinical data from all individuals attending the Emergency Department due to acute illicit drug toxicity. Surplus blood samples will be anonymised and analysed for toxicological profiling. The study will allow identification of emerging drug trends and will be shared contemporaneously with Public Health Scotland and inform the Scottish Government of current incidences to inform public health measures to tackle the drugs death crisis.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSurplus sample toxicology analysisAnonymised surplus blood sample will be analysed for drugs and their metabolites by way of Mass Spectrometry and LGC Group, Cambridge.

Timeline

Start date
2022-08-19
Primary completion
2023-08-19
Completion
2023-08-19
First posted
2022-04-14
Last updated
2022-09-19

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05329142. Inclusion in this directory is not an endorsement.